CN104800558A - Medicine for treating diabetes - Google Patents
Medicine for treating diabetes Download PDFInfo
- Publication number
- CN104800558A CN104800558A CN201510201690.1A CN201510201690A CN104800558A CN 104800558 A CN104800558 A CN 104800558A CN 201510201690 A CN201510201690 A CN 201510201690A CN 104800558 A CN104800558 A CN 104800558A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- diabetes
- radix
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating diabetes. The medicine comprises the following components in parts by weight: 9-20 parts of radix hedysari, 1.5-6 parts of leech, 6-12 parts of the fruit of Chinese wolfberry, 5-20 parts of gypsum, 2-6 parts of schisandra chinensis, 10-20 parts of Chinese yam, 6-12 parts of ophiopogon japonicus, 9-15 parts of cortex lycii, 9-15 parts of the root of kudzu vine and 6-12 parts of polygonatum odoratum. According to the invention, Chinese herbal medicines are carefully selected to be combined and through the functions of reducing blood glucose, regulating blood lipid, reducing blood pressure and other antioxidant functions, pancreas islet fibrosis is blocked, and heart and cerebral vessel series complications are prevented; microcirculation disturbance at lesion tissue parts is improved, an insulin resistance state is blocked, metabolic disorders caused by insulin resistance can be repaired, yin and yang are regulated, viscera are balanced, and functions of the kidney, liver, hear, spleen and stomach are perfected, so as to nourish the kidney and yin, replenish qi to invigorate the spleen, reduce phlegm and remove stasis and promote blood circulation to remove meridian obstruction, therefore, the effects of detoxifying and nourishing yin and eliminating inflammation are realized, the pancreas is protected, the metabolism function is corrected, diabetes can be effectively treated and patients are enabled to get better.
Description
Technical field
The present invention relates to medical art, specifically a kind of medicine for the treatment of diabetes and preparation method thereof.
Background technology
Diabetes divide type 1 diabetes and type 2 diabetes mellitus and gestational diabetes.Wherein type 1 diabetes is multiple is born in teenager, and insulin secretion lacks, and relies on insulinize and sustains life.Type 2 diabetes mellitus is more common in after 30 years old, old people, and the secretory volume of its insulin is not low even also higher, the cause of disease mainly body to insulin insensitivity (i.e. insulin resistant).Gestational diabetes is the insulin resistant coming from cell, but its insulin resistant is because the hormone of pregnancy women secretion causes, usually in a point puerperium spontaneous recovery.
China's diabetic occupies the whole world current diabetics number of China in first, 2013 up to 1.14 hundred million, just have 11 people to be diabeticss, and China about has more than 100 ten thousand diabetes new cases every year in every hundred people.
Reach tens of kinds for clinical treatment Chinese medicine and western medicine used at present, but owing to also not having substantial breakthrough so far to diabetes pathology, etiological study, treatment diabetes are still in and control blood glucose, glucose in urine increases the stage and prevents the conceptual phase of comprehensive complication.
The Western medicine for the treatment of diabetes mainly Novo Nordisk, gift come, Sanofi-Aventis, Bayer, etc. transnational medicine enterprise, wherein gift come, Novo Nordisk and Sanofi-Aventis, three medicines enterprises control the nearly 90% large hospital diabetes medicament of China and sell.The above-mentioned Western medicine of patient's long-term taking, can bring side effect to internal organs such as kidney, liver, the heart, spleen, stomaches.
For improving Rehabilitation level, domesticly continually develop various pure Chinese medicinal preparation, but mostly pay attention to control blood glucose, glucose in urine increases the stage.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of medicine for the treatment of diabetes; this medicine can regulate negative and positive, balance internal organs; improve kidney, liver, the heart, spleen, stomach function; with enriching yin and nourishing kidney, replenishing QI to invigorate the spleen, Huatan Zhuyu, promoting blood circulation to remove obstruction in the collateral, reach removing toxic substances yin nourishing, diminish inflammation; protection pancreas; correct metabolism, effectively treat diabetes, make patient recover normal.
For solving the problems of the technologies described above, a kind of medicine for the treatment of diabetes of the present invention, the component of this medicine is counted by weight: Radix Hedysari 9 ~ 20 parts, Hirudo 1.5 ~ 6 parts, Fructus Lycii 6 ~ 12 parts, 5 ~ 20 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 2 ~ 6 parts, Rhizoma Dioscoreae 10 ~ 20 parts, Radix Ophiopogonis 6 ~ 12 parts, Cortex Lycii 9 ~ 15 parts; Radix Puerariae 9 ~ 15 parts, Rhizoma Polygonati Odorati 6 ~ 12 parts.
The diabetes traditional Chinese medical science is called it " diabetes ", clinical with polydipsia, polyphagia, polyuria, become thin as cardinal symptom, the multifactor body deficiency of YIN, eating and drinking without temperance, surfeit are rich, multiple because of feelings will uncomfortable, upper damage lung Tianjin, to slander caused by gastric juice, lower consumption kidney water.Its pathological changes is dirty at lung spleen (stomach) kidney three, and intense heat due to deficiency of YIN is initial period, and deficiency of both QI and YIN is mid-term stage, and deficiency of both YIN and YANG has then developed into the home to return to stage.
We are theoretical according to Chinese traditional treatment; selected Chinese herbal medicine compatibility produces synergism; regulate negative and positive, balance internal organs, improve kidney, liver, the heart, spleen, stomach function, with enriching yin and nourishing kidney, replenishing QI to invigorate the spleen, Huatan Zhuyu, promoting blood circulation to remove obstruction in the collateral; reach removing toxic substances yin nourishing; diminish inflammation, protection pancreas, corrects metabolism; effective treatment diabetes, make patient recover normal.
As the further improvement to the technical program, the component of this medicine is counted by weight: Radix Hedysari 12 ~ 17 parts, Hirudo 3 ~ 5 parts, Fructus Lycii 8 ~ 10 parts, 7 ~ 18 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 3 ~ 5 parts, Rhizoma Dioscoreae 12 ~ 18 parts, Radix Ophiopogonis 8 ~ 10 parts, Cortex Lycii 11 ~ 13 parts; Radix Puerariae 11 ~ 13 parts, Rhizoma Polygonati Odorati 8 ~ 10 parts.
As the further improvement to the technical program, the component of this medicine is counted by weight: Radix Hedysari 15 parts, Hirudo 4 parts, Fructus Lycii 9 parts, 13 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 4 parts, Rhizoma Dioscoreae 15 parts, Radix Ophiopogonis 9 parts, Cortex Lycii 12 parts; Radix Puerariae 12 parts, Rhizoma Polygonati Odorati 9 parts.
As the further improvement to the technical program, the component of this medicine is counted by weight: Radix Hedysari 13 parts, Hirudo 4 parts, Fructus Lycii 10 parts, 15 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 5 parts, Rhizoma Dioscoreae 14 parts, Radix Ophiopogonis 10 parts, Cortex Lycii 13 parts; Radix Puerariae 13 parts, Rhizoma Polygonati Odorati 10 parts.
Radix Hedysari, sweet, temperature.Return lung, spleen channel.Invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.For the weary virtual force of gas, anorexia and loose stool, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, deficiency of vital energy edema, difficult routed, blood deficiency and yellow complexion, interior-heat is quenched one's thirst; Chronic nephritis proteinuria, diabetes, the deficiency of vital energy is weak, anorexia and loose stool.
Radix Hedysari contains the active ingredients such as macronutrient, as carotene, vitamin B2, vitamin B6, nicotinic acid etc., can participate in the Conversion of energy of fat, by lipocatabolic acceleration, reduces serum cholesterol, improves carbohydrate tolerance simultaneously.Select Radix Hedysari compatibility, can strengthen heart contraction, improve blood circulation and oxygen delivery capacity, make coronary vasodilator and renal blood vessels expansion, and make whole body peripheral vasodilation, qi-blood circulating is freely contained, and makes hyperpietic's blood pressure drops.
Hirudo, salty, bitter, flat; Poisonous.Return Liver Channel; Removing blood stasis, removing blood stasis, stimulates the menstrual flow.For lump in the abdomen mass in the abdomen, blood stasis amenorrhea, injury from falling down.
The present invention selects Hirudo compatibility, the effect having expansion blood capillary, improve microcirculation, increase renal blood flow amount, thrombolytic, blood fat reducing, minimizing vascular resistance.
Fructus Lycii, property is sweet, flat, returns liver, kidney channel, nourishing the liver and kidney, replenishing vital essence to improve eyesight.For asthenia damage of essence, soreness of waist and knee joint, vertigo and tinnitus, interior-heat is quenched one's thirst, blood deficiency and yellow complexion, and blurred vision is failed to understand.
Select Fructus Lycii, it has suppression fat and accumulates in fiber, promotes hepatocellular new life, reduces the effect such as blood glucose and cholesterol; Endocrine gland has the effect activated with newborn, strengthens the secretion of hormone, removes the toxin accumulated in blood, thus can maintain the normal function of each histoorgan in body.Its beta-carotene contained also can strengthen human immune system's function simultaneously; Improve the physical function of patient.
Gypsum Fibrosum, sweet, pungent, Great Cold.Return lung, the heart, kidney channel.Life clearing away heat-fire, relieving restlessness is quenched the thirst.For fever caused by exogenous pathogenic factors, high hot excessive thirst, dyspnea and cough due to lung-heat, the high Sheng of stomach-fire, headache, toothache.Gypsum Fibrosum Preparatum removing dampness, granulation promoting, sore, hemostasis.External treatment ulcer being unable to heal, eczema pruritus, burn due to hot liquid or fire, traumatic hemorrhage.
Select Gypsum Fibrosum, it quenches one's thirst and promotes the production of body fluid, the thirst with desire to drink symptom of effective diabetes-alleviating people.
Rhizoma Dioscoreae, property is sweet, flat, returns spleen, lung, kidney channel.Spleen reinforcing nourishing the stomach, promote the production of body fluid lung benefiting, the kidney invigorating arresting seminal emission.For insufficiency of the spleen lack of appetite, incessant chronic diarrhea, the deficiency of the lung is breathed with cough, emission due to deficiency of the kidney, leukorrhagia, frequent micturition, and deficiency-heat is quenched one's thirst.Rhizoma Dioscoreae (parched with bran) spleen reinforcing stomach invigorating.For insufficiency of the spleen lack of appetite, loose stool of having loose bowels, leukorrhagia.
The present invention selects Rhizoma Dioscoreae compatibility, and the extract of Rhizoma Dioscoreae has preventive and therapeutic action to the diabetes that alloxan causes, and the blood glucose that can cause antiadrenergic drug or glucose raises.The compositions such as dioscin contained by it is former, lymphatic temperament, free amino acid, vitamin C, can regulate intestinal tube to move, aid digestion, promote cellular immunization and humoral immunization, and have antioxidation.
Radix Ophiopogonis, sweet, micro-hardship, is slightly cold.GUIXIN, lung, stomach warp, YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire.For dryness of the lung dry cough, chronic consumptive disease is coughed, and Tianjin wound is thirsty, and vexed insomnia, interior-heat is quenched one's thirst, dryness of the intestine constipation, pharyngeal diphtheria.
Cortex Lycii, removing heat from blood removes and steams, lung heat clearing pathogenic fire reducing.For deficiency of YIN hectic fever, hectic fever due to YIN-deficiency night sweat, cough due to lung-heat, spitting of blood, epistaxis, interior-heat is quenched one's thirst.
The present invention is Cortex Lycii compatibility selectively, the effect that can reach vasodilator, reduce triglyceride, reduce blood glucose, blood pressure.
Radix Puerariae is sweet, pungent, cool.Return spleen, stomach warp.Expelling pathogenic factors from muscles for reducing heat, promotes the production of body fluid, rash, yang invigorating antidiarrheal.For fever caused by exogenous pathogens headache, stiffness of the nape, thirsty, quench one's thirst, measles without adequate eruption, hematodiarrhoea, has loose bowels; Hypertension neck pain.
The present invention selects Radix Puerariae compatibility, can improve the carbohydrate tolerance of human body, the effect of coronary artery dilator and external perihaemal canal resistance, blood sugar lowering, blood fat reducing, alleviates arteriosclerosis and Mottling formation.
Rhizoma Polygonati Odorati, sweet, be slightly cold.Attach to the lung and stomach meridians.Nourishing YIN to relieve dryness, promoting the production of body fluid to quench thirst.For lung stomach-Yin wound, cough caused by dryness-heat, dry throat and mouth, interior-heat is quenched one's thirst.
Select Rhizoma Polygonati Odorati, its sweet in the mouth, greasiness, soft and moist edible, be longer than yin nourishing, mend and oiliness, cold not dry, have the merit of " tonification the five internal organs, nourish QI and blood, flat benefit and moistening, and hold concurrently except wind heat ", the triglyceride in human body, cholesterolemia and B-lipoprotein can be made to decline.
This medicine components is concocted after cleaning, then pulverizing, incapsulates, 0.5 gram every or 1 gram after crossing 100 mesh sieves.For increasing the medical effect of the technical program further, can select genuine natural crude drugs, its wild environment is contaminated few, and side effect is little, more remarkable treatment effect.
Beneficial effect of the present invention is:
(1) selected Chinese herbal medicine compatibility, produce synergism, pass through blood sugar lowering, adjust fat, the serial anti-oxidation function such as blood pressure lowering, suppresses sugared toxicity, vascular endothelial function that Fatty toxicity causes damage, insulitis reaction block islets of langerhans fibrotic processes, increase receptor to the sensitivity of insulin, prevent the heart, cerebrovascular serious complications occurs.Meanwhile, pharmaceutically active substance expands the effective blood flow by increasing impaired pathological tissues, improves disease damage tissue place, local microcirculation disturbance, thus blocks insulin-resistant states, repair the metabolism disorder that insulin resistant causes, treating both the principal and secondary aspects of a disease.
(2) compared with other Chinese medicines of the prior art, this technology have employed distinct combined traditional Chinese medicine, and it is simple that selected component has component, and not containing famous and precious medicine, thus cost is low, alleviates the financial burden of patient.
This programme clinical application effect is good, and its clinical practice statistical result is as follows:
1, clinical data: we, in the health hospital clinical application of Yanggu County China, in a year of statistics in January, 2014-December, treat diabetic 276 people altogether; Mean age 52; Wherein, medical history is case 197 people of 1-2, the medical history case of more than 2 years 79 people.
2, efficacy assessment standard:
(1) cure, clinical symptom disappearance, and to cure in latter 1 year non-recidivist for curing.
(2) effective, the state of an illness is clearly better, and dizzy, unable symptom obviously alleviates; Blood glucose obviously reduces.
(3) invalid, after treatment, symptom is without significant change.
3, Therapeutic Method: medical history is case 197 people of 1-2, takes 2 courses for the treatment of of this prescription, 3 months 16 totally months courses for the treatment of; The medical history case of more than 2 years 79 people, treats 3-6 the course for the treatment of of the course for the treatment of; Treatment consumption: adult every day three times, 0.5 gram every, each 2 ~ 4.
4, therapeutic outcome: cure 226 people's (clinical symptom disappearance, and to cure in latter 1 year non-recidivist for curing), effective case 39 people (state of an illness is clearly better), Ineffective Cases 11 people (after treatment, symptom is without significant change), cure rate is 82%, and effective percentage is 96%.
5, part treat case is as follows:
(1) Chen man 51 years old Henan Province blue or green Feng County watt rural area, the home people, suffer from diabetes 5 years, take diabetes pill day 10, metformin hydrochloride day 2, occur that foot numbness of hand is wooden, unable, urine is foamed.Blood glucose assessment result is 10.63.Take diabetes capsule course for the treatment of (3 months), every day three times, 0.5 gram every, each 3.Blood glucose drops to 8.70, and Western medicine respectively subtracts half, foot numbness of hand wood, unable disappearance.Take Western medicine no longer use after two courses for the treatment of of diabetes capsule, urine is foamed disappearance.Blood glucose drops to 6.08, takes drug withdrawal after three courses for the treatment of of diabetes capsule, and 4 months blood glucose assessment results are in normal.
(2) Young female 60 years old Heze city of Shandong province Xincheng District, Dongming County citizen, suffer from diabetes 3 years, take metformin hydrochloride day 4.Occur dizzy, unable.Blood glucose assessment result is 17.20.Take a course for the treatment of of diabetes capsule, every day three times, 0.5 gram every, each 2 ~ 4.It is dizzy, unable transference cure.Take metformin hydrochloride and change day 2 into, continue to take diabetes capsule, after two courses for the treatment of, Western medicine is no longer used.Blood glucose assessment result is 11.53, and after taking three courses for the treatment of of diabetes capsule, blood glucose assessment result is 5.48, and drug withdrawal 6 months results of laboratory test are normal.
(3) the rural people in so-and-so stockaded village in the Lankao County Meng of man 45 years old Henan Province, hole, suffer from diabetes 1 year, take metformin hydrochloride day 2, occur dizzy, unable.Blood glucose assessment result is 6.40.Take diabetes capsule, every day three times, 0.5 gram every, each 2 ~ 4.After the course for the treatment of, dizzy, unable disappearance.Blood glucose assessment result is 5.71, to take after two courses for the treatment of of diabetes capsule result of laboratory test in normal.Drug withdrawal 6 months results of laboratory test are stablized.
(4) Zhang Qiu town, Yanggu County, Dong Shi female 47 years old Shandong Province villager, suffers from diabetes 4 years, occurs unable, dizzy.Take metformin hydrochloride day 2, blood glucose assessment result is 17.40.After taking a course for the treatment of of diabetes capsule, dizzyly to disappear.Blood glucose assessment result is 10.60, takes metformin hydrochloride day 1, takes diabetes capsule every day three times, 0.5 gram every, each 2 ~ 4.After two courses for the treatment of, Western medicine is use no longer, and blood glucose assessment result is 6.52.Taking result of laboratory test after three courses for the treatment of of diabetes capsule is that after 5.67, one year, result of laboratory test is normal.
(5) Yang man 54 years old Liaocheng of Shandong Province citizen, suffer from diabetes 5 years, take metformin hydrochloride day 2, beat insulin needle day 2 times.Blood glucose assessment result is 16.10, and after taking a course for the treatment of of diabetes capsule, take metformin hydrochloride day 1, blood glucose assessment result is 9.20.Take diabetes capsule every day three times, 0.5 gram every, each 4.After two courses for the treatment of, Western medicine is use no longer, and insulin needle day makes a call to 1 time, and after taking three courses for the treatment of of diabetes capsule, insulin needle is use no longer, and blood glucose assessment result is 5.91.Drug withdrawal result of laboratory test later six months is normal.
(6) Zhang man 49 years old Handan in Hebei province Guanyao County Xu Cun rural area people, suffer from diabetes 2 years, and beat insulin needle day 4 times, blood glucose assessment result is 16.30.After taking a course for the treatment of of diabetes capsule, insulin needle day 2 times, blood glucose assessment result is 10.06, takes diabetes capsule every day three times, 0.5 gram every, each 2 ~ 4.After two courses for the treatment of, blood glucose assessment result is 8.74.Insulin needle day 1 time, after taking three courses for the treatment of of diabetes capsule, insulin needle is use no longer, and blood glucose assessment result is 5.73.Drug withdrawal after 9 months blood glucose assessment result within normal.
Detailed description of the invention
Embodiment 1
Treat a medicine for diabetes, the component of this medicine is counted by weight: Radix Hedysari 9 ~ 20 parts, Hirudo 6 parts, Fructus Lycii 6 parts, 20 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 6 parts, Rhizoma Dioscoreae 20 parts, Radix Ophiopogonis 12 parts, Cortex Lycii 15 parts; Radix Puerariae 15 parts, Rhizoma Polygonati Odorati 12 parts.
Embodiment 2
Treat a medicine for diabetes, the component of this medicine is counted by weight: Radix Hedysari 9 ~ 20 parts, Hirudo 6 parts, Fructus Lycii 6 parts, 5 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 2 parts, Rhizoma Dioscoreae 10 parts, Radix Ophiopogonis 6 parts, Cortex Lycii 9 parts; Radix Puerariae 9 parts, Rhizoma Polygonati Odorati 6 parts.
Embodiment 3
Treat a medicine for diabetes, the component of this medicine is counted by weight: Radix Hedysari 12 parts, Hirudo 3 parts, Fructus Lycii 8 parts, 7 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 3 parts, Rhizoma Dioscoreae 12 parts, Radix Ophiopogonis 8 parts, Cortex Lycii 11 parts; Radix Puerariae 11 parts, Rhizoma Polygonati Odorati 8 parts.
Embodiment 4
Treat a medicine for diabetes, the component of this medicine is counted by weight: Radix Hedysari 17 parts, Hirudo 5 parts, Fructus Lycii 10 parts, 8 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 5 parts, Rhizoma Dioscoreae 18 parts, Radix Ophiopogonis 10 parts, Cortex Lycii 13 parts; Radix Puerariae 13 parts, Rhizoma Polygonati Odorati 10 parts.
Embodiment 5
Treat a medicine for diabetes, the component of this medicine is counted by weight: Radix Hedysari 15 parts, Hirudo 4 parts, Fructus Lycii 9 parts, 13 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 4 parts, Rhizoma Dioscoreae 15 parts, Radix Ophiopogonis 9 parts, Cortex Lycii 12 parts; Radix Puerariae 12 parts, Rhizoma Polygonati Odorati 9 parts.
Embodiment 6
Treat a medicine for diabetes, the component of this medicine is counted by weight: Radix Hedysari 13 parts, Hirudo 4 parts, Fructus Lycii 10 parts, 15 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 5 parts, Rhizoma Dioscoreae 14 parts, Radix Ophiopogonis 10 parts, Cortex Lycii 13 parts; Radix Puerariae 13 parts, Rhizoma Polygonati Odorati 10 parts.
The selected Chinese herbal medicine compatibility of the technical program, pass through blood sugar lowering, adjust fat, the serial anti-oxidation function such as blood pressure lowering, suppress sugared toxicity, vascular endothelial function that Fatty toxicity causes damage, insulitis reaction block islets of langerhans fibrotic processes, increase receptor to the sensitivity of insulin, prevent the heart, cerebrovascular serious complications occurs.Meanwhile, pharmaceutically active substance expands the effective blood flow by increasing impaired pathological tissues, improves disease damage tissue place, local microcirculation disturbance, thus blocks insulin-resistant states, repair the metabolism disorder that insulin resistant causes, treating both the principal and secondary aspects of a disease.And compared with other Chinese medicines of the prior art, this technology have employed distinct combined traditional Chinese medicine, it is simple that selected component has component, and not containing famous and precious medicine, thus cost is low, alleviates the financial burden of patient.
Claims (4)
1. treat a medicine for diabetes, it is characterized in that, the component of this medicine is counted by weight: Radix Hedysari 12 ~ 20 parts, Hirudo 2 ~ 6 parts, Fructus Lycii 6 ~ 12 parts, 6 ~ 20 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 3 ~ 6 parts, Rhizoma Dioscoreae 11 ~ 20 parts, Radix Ophiopogonis 7 ~ 11 parts, Cortex Lycii 9 ~ 15 parts; Radix Puerariae 9 ~ 15 parts, Rhizoma Polygonati Odorati 7 ~ 12 parts.
2. a kind of medicine for the treatment of diabetes according to claim 1, it is characterized in that, the component of this medicine is counted by weight: Radix Hedysari 12 ~ 17 parts, Hirudo 3 ~ 5 parts, Fructus Lycii 8 ~ 10 parts, 7 ~ 18 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 3 ~ 5 parts, Rhizoma Dioscoreae 12 ~ 18 parts, Radix Ophiopogonis 8 ~ 10 parts, Cortex Lycii 11 ~ 13 parts; Radix Puerariae 11 ~ 13 parts, Rhizoma Polygonati Odorati 8 ~ 10 parts.
3. a kind of medicine for the treatment of diabetes according to claim 2, it is characterized in that, the component of this medicine is counted by weight: Radix Hedysari 15 parts, Hirudo 4 parts, Fructus Lycii 9 parts, 13 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 4 parts, Rhizoma Dioscoreae 15 parts, Radix Ophiopogonis 9 parts, Cortex Lycii 12 parts; Radix Puerariae 12 parts, Rhizoma Polygonati Odorati 9 parts.
4. a kind of medicine for the treatment of diabetes according to claim 2, it is characterized in that, the component of this medicine is counted by weight: Radix Hedysari 13 parts, Hirudo 4 parts, Fructus Lycii 10 parts, 15 parts, Gypsum Fibrosum, Fructus Schisandrae Chinensis 5 parts, Rhizoma Dioscoreae 14 parts, Radix Ophiopogonis 10 parts, Cortex Lycii 13 parts; Radix Puerariae 13 parts, Rhizoma Polygonati Odorati 10 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510201690.1A CN104800558B (en) | 2015-04-27 | 2015-04-27 | A kind of drug for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510201690.1A CN104800558B (en) | 2015-04-27 | 2015-04-27 | A kind of drug for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104800558A true CN104800558A (en) | 2015-07-29 |
| CN104800558B CN104800558B (en) | 2018-06-12 |
Family
ID=53686041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510201690.1A Active CN104800558B (en) | 2015-04-27 | 2015-04-27 | A kind of drug for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104800558B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109528927A (en) * | 2018-12-27 | 2019-03-29 | 广西悬壶生物科技有限公司 | The Chinese medicine for treating diabetes |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6124597A (en) * | 1984-07-12 | 1986-02-03 | Yamanouchi Pharmaceut Co Ltd | Antidiabetic agent |
| CN1097322A (en) * | 1993-07-16 | 1995-01-18 | 郭庆贺 | Oral liquid for decreasing blood sugar and compound method thereof |
| CN103330836A (en) * | 2013-07-15 | 2013-10-02 | 李兴阜 | Traditional Chinese medicine composition for treating diabetes mellitus, and application of traditional Chinese medicine composition |
-
2015
- 2015-04-27 CN CN201510201690.1A patent/CN104800558B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6124597A (en) * | 1984-07-12 | 1986-02-03 | Yamanouchi Pharmaceut Co Ltd | Antidiabetic agent |
| CN1097322A (en) * | 1993-07-16 | 1995-01-18 | 郭庆贺 | Oral liquid for decreasing blood sugar and compound method thereof |
| CN103330836A (en) * | 2013-07-15 | 2013-10-02 | 李兴阜 | Traditional Chinese medicine composition for treating diabetes mellitus, and application of traditional Chinese medicine composition |
Non-Patent Citations (4)
| Title |
|---|
| 兰水中等: "《常见病单味中药新药》", 31 May 2013 * |
| 孙炜华: "《糖尿病药膳疗法》", 31 May 2005 * |
| 谢东泽: "《超越：中药西用在治疗结缔组织病中的探索和实践》", 31 October 2012 * |
| 邱文清等: "《常用中草药汇编：原植物彩色图鉴》", 31 May 2012 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109528927A (en) * | 2018-12-27 | 2019-03-29 | 广西悬壶生物科技有限公司 | The Chinese medicine for treating diabetes |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104800558B (en) | 2018-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103690783B (en) | Chinese medicine preparation being used for the treatment of diabetes and preparation method thereof | |
| CN104873808A (en) | Health tea capable of reducing high blood pressure, high blood sugar and high blood fat | |
| CN101537060A (en) | Medicine for treating AIDS | |
| CN101979020B (en) | Chinese medicinal preparation for treating high blood pressure | |
| CN104367753B (en) | A kind of Chinese medicine composition for treating diabetes B | |
| CN101530565B (en) | Chinese traditional medicine preparation used for curing diabetes and preparation method thereof | |
| CN102949571B (en) | Medicine for treating chronic osteomyelitis | |
| CN104800558A (en) | Medicine for treating diabetes | |
| CN101843843A (en) | Chinese medicament for treating diabetes | |
| CN101204550B (en) | Medicine for epilepsy | |
| CN102988747B (en) | Aristida triseta electuary for reducing hypertension, hyperglycemia and hyperlipidemia and preparation method thereof | |
| CN107496860A (en) | A kind of capsule medicine for treating diabetes and preparation method thereof | |
| CN102961575A (en) | Formula of traditional Chinese medicine for treating viral cardiac neurosis | |
| CN102293941B (en) | Chinese medicinal composition for treating diabetes mellitus | |
| CN105250758A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN107260978B (en) | Traditional Chinese medicine composition for treating hypertension and preparation method and application thereof | |
| CN106728835B (en) | A kind of Chinese medicine for treating diabetes | |
| CN104606511A (en) | Traditional Chinese medicine for preventing postoperative bounce phenomenon after minimally invasive therapy on lubar intervertebral disc protrusion | |
| CN103751496A (en) | Preparation method of traditional Chinese medicine for treating cold-dampness-disturbing-spleen-type hyperlipemia | |
| CN103623361A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis | |
| CN103961603B (en) | Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels | |
| CN103169854A (en) | Drug composition for treating diabetes mellitus and complication thereof | |
| CN103520647B (en) | A kind of adjustment hyperlipidemia Chinese medicine preparation | |
| CN108853380B (en) | Pharmaceutical composition for treating diabetes and preparation method and application thereof | |
| CN107149670A (en) | Treat medicinal herb tea of diabetes and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |